Document is current

Any future updates will be listed below

Differential clinicopathological features, treatments and outcomes in patients with Exon 19 deletion and Exon 21 L858R EGFR mutation-positive adenocarcinoma non-small-cell lung cancer

Crossref DOI link: https://doi.org/10.1136/bmjresp-2022-001492

Published Online: 2023-06-15

Published Print: 2023-06

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark